RYTM
$86.17-2.05%
Rhythm Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%US Stock Market 0.01%Russell 3000 0.008%
RYTM financial statements
The full income statement, balance sheet, and cash-flow statement for Rhythm Pharmaceuticals Inc. (RYTM), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 61.1M2024-09 61.5M2024-12 63.2M2025-03 63.6M2025-06 66.4M2025-09 66.7M2025-12 68.3M2026-03 68.5M2026-06 68.9M+12.6% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 190M+45.8% | 130M+68.1% | 77.4M+227.6% | 23.6M+649.5% | 3.15M | |
| Cost of revenue | 19.5M+45.8% | 13.4M+43.7% | 9.30M+336.1% | 2.13M+256.1% | 599K | |
| Research & development | 167M-29.7% | 238M+76.3% | 135M+24.2% | 109M+4.3% | 104M+15.1% | |
| Selling, general & administrative | 195M+35.1% | 144M+22.8% | 118M+27.7% | 92.0M+34.4% | 68.5M+48.5% | |
| Amortization of intangibles | — | — | 855K+10.5% | 774K+126.3% | 342K | |
| Provision for credit losses | 49.5M+67.0% | 29.6M+55.8% | 19.0M+418.9% | 3.67M+544.3% | 569K | |
| Operating income | -192M+27.7% | -266M-44.0% | -184M-2.9% | -179M-5.3% | -170M-24.5% | |
| Interest expense | 20.6M-0.1% | 20.6M+48.3% | 13.9M+167.1% | 5.20M | — | |
| Interest & investment income | — | — | — | — | 447K-82.7% | |
| Other non-operating income | 1.26M-43.5% | 2.24M+1078.4% | 190K+124.1% | -790K-100.8% | 100M+3777.5% | |
| Gain (loss) on equity securities | — | — | 366K | — | -50.0K-202.0% | |
| Pre-tax income | -196M+24.7% | -260M-41.4% | -184M-1.7% | -181M-160.2% | -69.6M | |
| Income tax | 497K+43.6% | 346K-38.7% | 564K | — | — | |
| -197M+24.6% | -261M-41.1% | -185M-2.0% | -181M-160.2% | -69.6M+48.0% | ||
| Net income to common | -202M+23.7% | -265M-43.3% | -185M-2.0% | -181M | — | |
| -$3.11+28.3% | -$4.34-35.6% | -$3.20+7.8% | -$3.47-147.9% | -$1.40+53.9% | ||
| EPS (basic) | -$3.11+28.3% | -$4.34-35.6% | -$3.20+7.8% | -$3.47-147.9% | -$1.40+53.9% | |
| Weighted-avg shares (basic) | 65.0M+6.5% | 61.0M+5.8% | 57.7M+10.7% | 52.1M+5.1% | 49.6M+12.4% | |
| Weighted-avg shares (diluted) | 65.0M+6.5% | 61.0M+5.8% | 57.7M+10.7% | 52.1M+5.1% | 49.6M+12.4% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 467M+24.8% | 374M+21.4% | 308M-13.0% | 354M+14.9% | 308M+69.8% | ||
| Cash & equivalents | 54.3M-39.1% | 89.1M+48.4% | 60.1M-52.9% | 128M+115.5% | 59.2M-41.3% | |
| Short-term investments | 335M+44.6% | 231M+7.3% | 216M+4.9% | 206M-12.7% | 236M+227.5% | |
| Cash & short-term investments | 389M+21.3% | 321M+16.2% | 276M-17.2% | 333M+13.0% | 295M+70.6% | |
| Accounts receivable | 26.1M+40.9% | 18.5M+24.5% | 14.9M+138.9% | 6.22M+507.2% | 1.02M | |
| Inventory | 25.8M+37.4% | 18.7M+117.3% | 8.62M+195.6% | 2.92M+2527.9% | 111K | |
| Prepaid expenses | 26.1M+59.5% | 16.4M+83.4% | 8.93M-24.4% | 11.8M-4.8% | 12.4M+39.7% | |
| Other current assets | 9.97M+13.2% | 8.80M+31.9% | 6.67M-10.0% | 7.42M+85.7% | 3.99M+31.0% | |
| 480M+22.4% | 392M+17.9% | 333M-13.0% | 382M+16.1% | 330M+76.1% | ||
| Property, plant & equipment | 1.10M+74.7% | 632K-52.9% | 1.34M-39.0% | 2.20M-21.9% | 2.81M-12.0% | |
| Operating lease right-of-use | 3.05M-12.3% | 3.48M+345.2% | 781K-33.9% | 1.18M-22.3% | 1.52M-15.8% | |
| Intangible assets | 5.32M-13.8% | 6.17M-12.2% | 7.03M-10.8% | 7.88M+69.2% | 4.66M | |
| Other non-current assets | 3.29M-55.1% | 7.33M-51.2% | 15.0M-9.9% | 16.7M | — | |
| 106M-8.3% | 116M+109.3% | 55.2M+38.7% | 39.8M-8.3% | 43.4M+141.3% | ||
| Accounts payable | 13.9M+13.1% | 12.3M+152.4% | 4.88M+1.8% | 4.80M-16.4% | 5.74M+17.1% | |
| Accrued liabilities | 83.9M+33.8% | 62.7M+29.8% | 48.3M+46.7% | 32.9M+9.3% | 30.1M+139.5% | |
| Deferred revenue | 194K-84.9% | 1.29M+0.0% | 1.29M-10.3% | 1.43M-79.5% | 7.00M | |
| Short-term & current debt | 7.30M+373.5% | 1.54M | — | — | — | |
| Current lease liability | 650K | 0.00-100.0% | 770K+12.6% | 684K+12.9% | 606K+13.3% | |
| Other current liabilities | 0.00-100.0% | 37.7M | — | — | — | |
| 210M-7.7% | 228M+39.7% | 163M+37.9% | 118M+160.6% | 45.4M+120.8% | ||
| Long-term debt | 101M-6.8% | 108M+2.0% | 106M | — | — | |
| Deferred revenue (non-current) | — | — | 106M+40.0% | 75.8M | — | |
| Non-current lease liability | 3.34M-15.1% | 3.94M+703.7% | 490K-61.1% | 1.26M-35.2% | 1.95M | |
| Operating lease liability (total) | — | — | 1.26M-35.2% | 1.94M-23.8% | 2.55M-17.3% | |
| Finance lease liability | — | — | — | — | 1.95M-23.8% | |
| 139M+540.0% | 21.7M-87.2% | 170M-35.8% | 264M-7.0% | 284M+70.6% | ||
| Preferred stock | 0.00 | — | — | — | — | |
| Common stock | 67.0K+9.8% | 61.0K+3.4% | 59.0K+5.4% | 56.0K+12.0% | 50.0K+13.6% | |
| Additional paid-in capital | 1.49B+26.7% | 1.18B+10.6% | 1.06B+9.2% | 974M+19.8% | 813M+29.9% | |
| Retained earnings | -1.35B-17.0% | -1.16B-29.1% | -895M-26.0% | -710M-34.2% | -529M-15.2% | |
| Accumulated other comprehensive income | -796K-1941.0% | -39.0K-129.1% | 134K+245.7% | -92.0K-9100.0% | -1.00K-102.0% | |
| Total liabilities & equity | 480M+22.4% | 392M+17.9% | 333M-13.0% | 382M+16.1% | 330M+76.1% | |
| Common shares issued | 67.2M+7.7% | 62.4M+5.0% | 59.4M+5.0% | 56.6M+12.6% | 50.3M+13.7% | |
| Common shares outstanding | 67.2M+7.7% | 62.4M+5.0% | 59.4M+5.0% | 56.6M+12.6% | 50.3M+13.7% | |
| Shares outstanding (cover) | 68.3M+8.0% | 63.2M+5.1% | 60.1M+6.0% | 56.7M+12.8% | 50.3M+0.3% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -116M-1.6% | -114M+16.4% | -136M+21.5% | -173M-18.8% | -146M-19.7% | ||
| Depreciation & amortization | 500K-28.6% | 700K-22.2% | 900K+0.4% | 896K+9.8% | 816K+18.3% | |
| Intangible amortization | — | — | 855K+10.5% | 774K+126.3% | 342K | |
| Share-based compensation | 66.8M+68.4% | 39.7M+21.9% | 32.6M+64.2% | 19.8M-4.7% | 20.8M+19.2% | |
| Deferred income taxes | 0.00 | 0.00 | 0.00 | — | — | |
| Change in receivables | 7.57M+107.7% | 3.65M-57.8% | 8.64M+66.2% | 5.20M+315.9% | 1.25M | |
| Change in inventory | 7.47M-26.1% | 10.1M+77.3% | 5.71M+103.4% | 2.81M+25409.1% | 11.0K | |
| -137M-184.7% | -48.2M-750.4% | -5.67M-120.2% | 28.0M+145.1% | -62.2M-139.2% | ||
| Capital expenditure | 953K | 0.00-100.0% | 47.0K-83.3% | 281K-35.3% | 434K+102.8% | |
| Free cash flow | -117M-2.4% | -114M+16.4% | -136M+21.6% | -174M-18.6% | -146M-19.8% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 218M+14.0% | 191M+157.2% | 74.4M-65.2% | 214M+28.4% | 166M+8186.8% | ||
| Long-term debt issued | 0.00 | 0.00-100.0% | 24.4M-66.3% | 72.3M | 0.00 | |
| Long-term debt repaid | 19.9M+54.4% | 12.9M+74.4% | 7.40M | 0.00 | 0.00 | |
| Common stock issued | 34.0M-13.1% | 39.1M-19.9% | 48.9M-62.7% | 131M-18.9% | 162M | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -34.8M-219.1% | 29.2M+143.2% | -67.6M-198.8% | 68.4M+264.2% | -41.7M-208.1% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 7.31B+106.5% | 3.54B+30.3% | 2.72B+65.6% | 1.64B+226.7% | 502M-66.3% | |
| P/S | 38.5×+41.6% | 27.2×-37.9% | 43.8×-55.5% | 98.5×-38.2% | 159.3× | |
| P/B | 52.6×-67.7% | 162.9×+1084.0% | 13.8×+135.8% | 5.8×+230.1% | 1.8×-80.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: RYTM’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all RYTM filings on SEC EDGAR → Not investment advice.